DNA

Epica International Appoints Alok K. Agrawal to Its Board of Directors

Seasoned technology and venture executive join to support Epica's continued global growth and innovation strategy. LANDRUM, SC / ACCESS Newswire…

1 month ago

eCap Announces Finalists for “Catalyst” — A Startup Showcase Advancing Real-World Innovation in Long-Term Care

18 early stage start-ups selected to demo their innovations for long-term care at eCapWest2025, with Randi Zuckerberg moderating the live…

1 month ago

Flagship Pioneering Unveils Expedition Medicines to Expand the Boundaries of Small Molecule Medicines with Generative Design

After three years of internal development, Expedition is building a generative AI platform for covalent drug discovery, supported by a…

1 month ago

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Artificial intelligence has reshaped nearly every industry, but drug discovery…

1 month ago

Investors at a Crossroads: Remote Monitoring, Wellness Apps, and Oversold Health IT Categories Face a 2025 Funding Recession as ROI Fatigue Sets In

Investor sentiment is cooling sharply across once-hot digital health sectors. LAS VEGAS, NV / ACCESS Newswire / October 21, 2025…

2 months ago

Investors at a Crossroads: Remote Monitoring, Wellness Apps, and Oversold Health IT Categories Face a 2025 Funding Recession as ROI Fatigue Sets In

Investor sentiment is cooling sharply across once-hot digital health sectors. LAS VEGAS, NV / ACCESS Newswire / October 21, 2025…

2 months ago

CellRight Technologies, LLC Announces Update and Senior Leadership Changes

CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives SAN ANTONIO, TX / ACCESS Newswire…

2 months ago

CellRight Technologies, LLC Announces Update and Senior Leadership Changes

CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives SAN ANTONIO, TX / ACCESS Newswire…

2 months ago

Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth

Unifying global IP rights and enabling up to $5 million in potential shareholder contributions, the agreement strengthens Telomir's foundation for…

2 months ago

Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth

Unifying global IP rights and enabling up to $5 million in potential shareholder contributions, the agreement strengthens Telomir's foundation for…

2 months ago